No increased risk of Kaposi sarcoma relapse in patients with controlled HIV‐1 infection after switching protease inhibitor‐based antiretroviral therapy

Corresponding Author

Department of Infectious and Tropical Diseases, Toulouse University Hospital and INSERM UMR1291 - CNRS UMR5051 – Université Toulouse III, Institut Toulousain des Maladies Infectieuses et Inflammatoires (Infinity), Toulouse, France

Correspondence

Guillaume Martin-Blondel, Department of Infectious and Tropical Diseases, Toulouse University Hospital and INSERM UMR1291 - CNRS UMR5051 – Université Toulouse III, Institut Toulousain des Maladies Infectieuses et Inflammatoires (Infinity), Place du Docteur Baylac, TSA 40031, CEDEX 9, 31059 Toulouse, France.

Email: martin-blondel.g@chu-toulouse.fr

Search for more papers by this author

留言 (0)

沒有登入
gif